Eyebright Medical Technology Beijing Co Ltd (688050) — Capital Reinvestment Ratio
Eyebright Medical Technology Beijing Co Ltd (688050) has a Capital Reinvestment Ratio of 0.28x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥76.92 Million) in capital expenditures (CN¥21.37 Million). See Eyebright Medical Technology Beijing Co free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eyebright Medical Technology Beijing Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Eyebright Medical Technology Beijing Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Eyebright Medical Technology Beijing Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Eyebright Medical Technology Beijing Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see 688050 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥369.15 Million | CN¥123.14 Million | ▼ -64.8% |
| 2024 | 0.95x | CN¥347.75 Million | CN¥329.48 Million | ▼ -42.1% |
| 2023 | 1.64x | CN¥226.27 Million | CN¥370.34 Million | ▲ +51.1% |
| 2022 | 1.08x | CN¥250.13 Million | CN¥271.03 Million | ▼ -23.6% |
| 2021 | 1.42x | CN¥219.30 Million | CN¥311.22 Million | ▲ +47.4% |
| 2020 | 0.96x | CN¥123.35 Million | CN¥118.73 Million | ▼ -65.7% |
| 2019 | 2.80x | CN¥50.49 Million | CN¥141.61 Million | ▲ +24.3% |
| 2018 | 2.26x | CN¥31.82 Million | CN¥71.81 Million | ▼ -70.3% |
| 2017 | 7.60x | CN¥4.15 Million | CN¥31.53 Million | — |